ES339028A1 - Improvements in or relating to cephalosporins - Google Patents

Improvements in or relating to cephalosporins

Info

Publication number
ES339028A1
ES339028A1 ES339028A ES339028A ES339028A1 ES 339028 A1 ES339028 A1 ES 339028A1 ES 339028 A ES339028 A ES 339028A ES 339028 A ES339028 A ES 339028A ES 339028 A1 ES339028 A1 ES 339028A1
Authority
ES
Spain
Prior art keywords
salt
acid
acid addition
addition salt
pyridinium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES339028A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of ES339028A1 publication Critical patent/ES339028A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

An N - (7 - acylamido - ceph - 3 - em - 3 - ylmethyl) - pyridinium - 4 - carboxylate is produced by (A) reacting a 7-acylamidocephalosporanic acid or a salt thereof with pyridine or a substituted pyridine in solution in a reaction medium in the presence of at least an equivalent equimolar proportion, calculated on the 7-acylamido cephalosporanic acid, of thiocyanate or iodide ions and recovering the resultant N-(7- acylamidoceph - 3 - em - 3 - yl - methyl)- pyridinium-4-carboxylate as its crude hydrothiocyanate or hydroidide acid addition salt (B) converting the crude hydrothiocyanate or hydroiodide acid addition salt from (A) to the betaine form by reacting said salt with a base, the betaine being recovered in an aqueous phase (C) if desired, passing the aqueous phase from (B) through one or more ion-exchangers and, if desired, decolouring absorbent, to remove further impurities, e.g. acidic and basic impurities as well as colourants (D) reacting the aqueous phase from (B) or (C) with an acid to form an insoluble acid addition salt (E) separating the acid addition salt from (D) from the mother liquor and converting the salt to the betaine form by reaction with a base. The examples relate to the preparation of N-(7-21- thienylacetamidoceph - 3 - em - 3 - ylmethyl)- pyridinium - 4 - carboxylate - (cephaloridine). The pyridine may be substituted by one or more alkyl, carboxy or carbamoyl groups. Specifications 912,541, 966,221, 1,028,563, 1,101,561, 1,101,562 and 1,132,621 are referred to.
ES339028A 1966-04-07 1967-04-07 Improvements in or relating to cephalosporins Expired ES339028A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1571966A GB1171603A (en) 1966-04-07 1966-04-07 Improvements in or relating to cephalosporins

Publications (1)

Publication Number Publication Date
ES339028A1 true ES339028A1 (en) 1968-07-01

Family

ID=10064258

Family Applications (1)

Application Number Title Priority Date Filing Date
ES339028A Expired ES339028A1 (en) 1966-04-07 1967-04-07 Improvements in or relating to cephalosporins

Country Status (10)

Country Link
AT (1) AT287189B (en)
BE (1) BE696775A (en)
CH (1) CH504472A (en)
DE (1) DE1695015C3 (en)
DK (1) DK136609C (en)
ES (1) ES339028A1 (en)
GB (1) GB1171603A (en)
GR (1) GR35150B (en)
NL (1) NL6704945A (en)
SE (1) SE370080B (en)

Also Published As

Publication number Publication date
DE1695015A1 (en) 1972-03-09
CH504472A (en) 1971-03-15
DK136609C (en) 1978-04-10
DE1695015C3 (en) 1978-05-03
GR35150B (en) 1968-08-21
DK136609B (en) 1977-10-31
SE370080B (en) 1974-09-30
NL6704945A (en) 1967-10-09
AT287189B (en) 1971-01-11
DE1695015B2 (en) 1977-09-22
GB1171603A (en) 1969-11-26
BE696775A (en) 1967-10-09

Similar Documents

Publication Publication Date Title
GB1383798A (en) Soap compositions
GB1073488A (en) Improvements in contact for direct receptionof printed circuit board
GB1256847A (en)
GB1419991A (en) Carboxyalkoxy succinic acid salts
ES339028A1 (en) Improvements in or relating to cephalosporins
GB1346544A (en) Silver allantoinate-containing compositions
GB1262560A (en) A method of stabilizing sodium hydrosulphite
GB1060133A (en) A derivative of -aminobenzylpenicillin
ES369724A1 (en) Recovery of lead values from solution
ES8300775A1 (en) Cephamycin C derivative and its preparation.
GB653993A (en) Process of producing silicic acid from alkali silicates
GB1017341A (en) Process for the production of barium salts
JPS5231094A (en) Preparation of cephalexin
GB915486A (en) Recovery of demethylchlortetracycline
IE35922L (en) Recovery of cephalothin salts
ES428937A1 (en) An improved procedure for the purification of aqueous sulfuric acid. (Machine-translation by Google Translate, not legally binding)
GB1018342A (en) Production of purified preparations of the kallikrein inactivator
GB1076981A (en) Improvements in the manufacture of lead 2:4-dinitroresorcinate
GB1206901A (en) A flux for zincking, tinning and leading
ES379724A1 (en) Method of preparing sodium nitrilotriacetate
GB1191493A (en) Method for preparing Methylene Bis (Thiocyanate)
GB946902A (en) Improvements in or relating to the recovery of glutamic acid from fermentation media
CA541581A (en) Recovery of 2,4,5-trichlorophenoxyacetic acid from the sodium salt
GB1075162A (en) Process of preparing purified lac
GB875111A (en) A process for the production of chromium trioxide

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170626